• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白蛋白-胆红素结合机制。

Albumin-bilirubin binding mechanism.

作者信息

Jacobsen J, Brodersen R

出版信息

J Biol Chem. 1983 May 25;258(10):6319-26.

PMID:6853485
Abstract

After binding of bilirubin to human serum albumin (1:1), a train of relaxational changes of conformation takes place. The late part of these processes, occurring in the time interval 1-500 s, has been studied by recording the changes of light absorption. Similar processes have been demonstrated after binding of fatty acid anion to the bilirubin-albumin complex as well as after a pH-jump from 6 to 9. Solvent perturbation spectra obtained on the addition of 20% sucrose have failed to demonstrate exposure of the bilirubin chromophores in the complex to the surrounding medium. Xanthobilirubinate which has a single dipyrrolic chromophore compared to the two of bilirubin is bound to albumin in competition with bilirubin, as concluded from co-binding studies with monoacetyldiaminodiphenylsulfone and diazepam, probing two different binding functions of the albumin molecule. Late conformational changes were absent after binding of xanthobilirubinate. Binding of fatty acid to the complex and a pH-jump did not affect the spectrum of xanthobilirubinate-human serum albumin. The findings can be explained by a model, previously proposed, in which the late spectral changes are affected by rotation of one half-domain of albumin, binding one bilirubin chromophore, relative to another half-domain to which the second bilirubin chromophore is bound, whereby a change of exiton splitting occurs. Such changes are not seen with the complex of xanthobilirubinate and albumin, since only a single chromophore is present.

摘要

胆红素与人类血清白蛋白以1:1结合后,会发生一系列构象松弛变化。这些过程的后期,即发生在1 - 500秒时间间隔内的部分,已通过记录光吸收变化进行了研究。脂肪酸阴离子与胆红素 - 白蛋白复合物结合后,以及pH从6跃升至9后,也观察到了类似的过程。添加20%蔗糖后获得的溶剂扰动光谱未能证明复合物中胆红素发色团暴露于周围介质中。与胆红素的两个双吡咯发色团相比,具有单个双吡咯发色团的黄胆胆红素与白蛋白结合时会与胆红素竞争,这是通过与单乙酰二氨基二苯砜和地西泮的共结合研究得出的结论,该研究探测了白蛋白分子的两种不同结合功能。黄胆胆红素结合后不存在后期构象变化。脂肪酸与复合物的结合以及pH跃变不会影响黄胆胆红素 - 人类血清白蛋白的光谱。这些发现可以用先前提出的一个模型来解释,在该模型中,后期光谱变化受白蛋白一个半结构域的旋转影响,该半结构域结合一个胆红素发色团,相对于结合第二个胆红素发色团的另一个半结构域,从而发生激子分裂的变化。黄胆胆红素与白蛋白的复合物未观察到此类变化,因为只存在单个发色团。

相似文献

1
Albumin-bilirubin binding mechanism.白蛋白-胆红素结合机制。
J Biol Chem. 1983 May 25;258(10):6319-26.
2
Stopped-flow studies of spectral changes in bilirubin-human serum albumin following an alkaline pH jump and following binding of bilirubin.
J Biol Chem. 1987 Nov 5;262(31):14939-44.
3
Cobinding of bilirubin and sulfonamide and of two bilirubin molecules to human serum albumin: a site model.
Arch Biochem Biophys. 1987 Feb 1;252(2):561-9. doi: 10.1016/0003-9861(87)90063-4.
4
Affinity labeling of the primary bilirubin binding site of human serum albumin.
J Biol Chem. 1976 Feb 10;251(3):801-7.
5
Conformational changes in the bilirubin-human serum albumin complex at extreme alkaline pH.在极端碱性pH条件下胆红素-人血清白蛋白复合物的构象变化
Biochem J. 1986 Jun 1;236(2):365-9. doi: 10.1042/bj2360365.
6
Fatty acid enhancement of the quantum yield for the formation of lumirubin from bilirubin bound to human albumin.脂肪酸对胆红素与人血清白蛋白结合形成lumirubin的量子产率的增强作用。
Pediatr Res. 1987 Jun;21(6):530-3. doi: 10.1203/00006450-198706000-00003.
7
Multiple binding of bilirubin to human serum albumin and cobinding with laurate.胆红素与人血清白蛋白的多重结合及与月桂酸的共结合。
Arch Biochem Biophys. 1988 Feb 1;260(2):811-21. doi: 10.1016/0003-9861(88)90512-7.
8
Ceftriaxone binding to human serum albumin: competition with bilirubin.头孢曲松与人血清白蛋白的结合:与胆红素的竞争。
Mol Pharmacol. 1989 Sep;36(3):478-83.
9
Cobinding of bilirubin and laurate to human serum albumin: spectroscopic characterization of stoichiometric complexes.
Arch Biochem Biophys. 1988 Oct;266(1):189-96. doi: 10.1016/0003-9861(88)90249-4.
10
Binding of bilirubin to low-affinity sites of human serum albumin in vitro followed by co-crystallization.体外结合胆红素与人血清白蛋白的低亲和力部位,随后进行共结晶。
Scand J Clin Lab Invest. 1972;29(4):433-46. doi: 10.3109/00365517209080263.

引用本文的文献

1
Bilirubin metabolism and its application in disease prevention: mechanisms and research advances.胆红素代谢及其在疾病预防中的应用:机制与研究进展
Inflamm Res. 2025 May 24;74(1):81. doi: 10.1007/s00011-025-02049-w.
2
Urobilin Derived from Bilirubin Bioconversion Binds Albumin and May Interfere with Bilirubin Interacting with Albumin: Implications for Disease Pathology.源自胆红素生物转化的尿胆素与白蛋白结合,可能干扰胆红素与白蛋白的相互作用:对疾病病理学的影响。
Biomedicines. 2025 Jan 26;13(2):302. doi: 10.3390/biomedicines13020302.
3
Characterization of Synovial Fluid Components: Albumin-Chondroitin Sulfate Interactions Seen through Molecular Dynamics.
滑液成分的表征:通过分子动力学观察白蛋白与硫酸软骨素的相互作用
Materials (Basel). 2022 Oct 6;15(19):6935. doi: 10.3390/ma15196935.
4
Molecular Mechanisms of Acute Organophosphate Nephrotoxicity.急性有机磷肾病的分子机制。
Int J Mol Sci. 2022 Aug 9;23(16):8855. doi: 10.3390/ijms23168855.
5
Serum Bilirubin and Sperm Quality in Adult Population.成年人群中的血清胆红素与精子质量
Toxics. 2022 May 30;10(6):295. doi: 10.3390/toxics10060295.
6
Albumin-Hyaluronan Interactions: Influence of Ionic Composition Probed by Molecular Dynamics.白蛋白-透明质酸相互作用:离子组成对分子动力学探测的影响。
Int J Mol Sci. 2021 Nov 16;22(22):12360. doi: 10.3390/ijms222212360.
7
Albumin in patients with liver disease shows an altered conformation.肝病患者的白蛋白会发生构象改变。
Commun Biol. 2021 Jun 14;4(1):731. doi: 10.1038/s42003-021-02269-w.
8
Hydroxyapatite reinforced inorganic-organic hybrid nanocomposite as high-performance adsorbents for bilirubin removal and in pig models.羟基磷灰石增强无机-有机杂化纳米复合材料作为用于去除胆红素的高性能吸附剂及在猪模型中的应用
Bioact Mater. 2021 May 24;6(12):4772-4785. doi: 10.1016/j.bioactmat.2021.05.017. eCollection 2021 Dec.
9
The Universal Soldier: Enzymatic and Non-Enzymatic Antioxidant Functions of Serum Albumin.通用战士:血清白蛋白的酶促和非酶促抗氧化功能
Antioxidants (Basel). 2020 Oct 9;9(10):966. doi: 10.3390/antiox9100966.
10
Crigler-Najjar Syndrome Type 1: Pathophysiology, Natural History, and Therapeutic Frontier.克里格勒-纳贾尔综合征 1 型:病理生理学、自然史和治疗前沿。
Hepatology. 2020 Jun;71(6):1923-1939. doi: 10.1002/hep.30959. Epub 2020 Feb 5.